Paper Details

  1. Home
  2. Paper Details

<i>In Vitro</i> Synergistic Effects of Omadacycline with Other Antimicrobial Agents against Mycobacterium abscessus.

Author: AonoAkio, AsamiTakahiro, ChikamatsuKinuyo, FujiwaraKeiji, IgarashiYuriko, KamadaKeisuke, MitaraiSatoshi, MorimotoKozo, MorishigeYuta, MuraseYoshiro, TakakiAkiko, YamadaHiroyuki

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Omadacycline (OMC), a novel tetracycline, was investigated for its in vitro activity against Mycobacterium abscessus species (MABS), a growing clinical concern. OMC showed promising activity against MABS strains, with synergistic effects when combined with other antibiotics. OMC was particularly effective against rough-morphotype MABS strains, suggesting a potential for treating difficult-to-treat MABS infections.
Paper Details　
Original Abstract of the Article :
The clinical importance of Mycobacterium abscessus species (MABS) infections has been increasing. However, the standard treatment regimens recommended in the current guidelines often result in unfavorable outcomes. Therefore, we investigated the <i>in vitro</i> activity of omadacycline (OMC), a nove...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269086/

データ提供：米国国立医学図書館（NLM）

Omadacycline: A New Weapon in the Fight Against Mycobacterium abscessus

Mycobacterium abscessus (MABS) infections are a growing concern, posing challenges for treatment. This research investigates the potential of omadacycline (OMC), a novel tetracycline, as a new therapeutic option for MABS infections. The study evaluated the in vitro activity of OMC against MABS strains and explored its potential for synergistic effects when combined with other antimicrobial agents. Think of this as a group of scientists studying the intricate mechanisms of a desert ecosystem, searching for new ways to combat a disease that threatens the balance of life.

Omadacycline: A Powerful Weapon Against MABS

The study found that OMC exhibited significant in vitro activity against MABS strains, often showing synergy when combined with other antibiotics. These results suggest that OMC could be a promising therapeutic option for MABS infections, potentially offering a more effective and targeted approach. This is like discovering a new type of weapon that can effectively target a specific threat in the desert ecosystem, helping to restore balance and protect the community.

Health Implications and Everyday Applications

This research underscores the need for ongoing research and development of new antibiotics to combat emerging and challenging infections, like those caused by MABS. Just as a camel caravan needs to adapt to changing desert conditions and learn to navigate new challenges, we need to stay ahead of the curve in the fight against infectious diseases.

Dr. Camel's Conclusion

This research provides a promising avenue for treating MABS infections. Just as a camel relies on its resilience and adaptability to survive in the harsh desert, we need to continuously explore new solutions to overcome medical challenges and improve patient outcomes. Omadacycline holds potential as a valuable tool in our arsenal against MABS infections.

Date :
  1. Date Completed 2023-06-19
  2. Date Revised 2023-11-20
Further Info :

Pubmed ID

37154742

DOI: Digital Object Identifier

PMC10269086

Related Literature

Article Analysis
・Effects of tedizolid
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.